Sanara MedTech Inc.

Total Valuation

Sanara MedTech Inc. carries a market capitalization of 192.17M, placing it among publicly traded companies globally. Its enterprise value stands at 182.68M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Sanara MedTech Inc. currently has 9.17M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 1.38, and the price-to-book ratio stands at -1.99.

Enterprise Valuation

On an enterprise value basis, Sanara MedTech Inc. trades at an EV/EBITDA multiple of 15.41 and an EV/FCF ratio of 11.07. The EV/Sales ratio of 1.70 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 21.62 provides insight into valuation relative to core operating earnings.

Financial Position

Sanara MedTech Inc. maintains a current ratio of 2.28, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 689.01, indicating elevated leverage, while an interest coverage ratio of 1.64 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Stock Price Statistics

Sanara MedTech Inc.'s stock has declined approximately -28.11107% over the past 52 weeks. The 50-day moving average sits at 19.58, while the 200-day moving average is 24.13.

Income Statement

Over the trailing twelve months, Sanara MedTech Inc. generated 107.51M in revenue and converted that into -33.58M in net income, yielding earnings per share of -0.22. EBITDA reached 11.86M, while operating income came in at 8.45M.

Balance Sheet

Sanara MedTech Inc. holds 13.59M in cash and equivalents against 48.37M in total debt, resulting in a net debt position of 32.63M. Total book value stands at -74.49M, with working capital of 17.50M providing operational flexibility.

Cash Flow

Sanara MedTech Inc. produced 6.32M in operating cash flow over the past twelve months. After subtracting -2.95M in capital expenditures, free cash flow totaled 3.37M - equivalent to 0.39 per share.

Margins

Sanara MedTech Inc. operates with a gross margin of 92.92, reflecting its pricing power and cost economics. The operating margin of 7.86 and net profit margin of -31.23 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Sanara MedTech Inc.'s most recent stock split took place on May 10, 2019 with a 100:1 split ratio.

Scores

Sanara MedTech Inc. posts an Altman Z-Score of 2.51, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.